Broad Institute
A biomedical research institution jointly founded by MIT and Harvard University, focused on frontier fields including genomics and cancer biology. It operates as one of the leading life sciences research centers globally, advancing the understanding of the molecular basis of disease.
Timeline (last 90 days)
PRISM is a high-throughput drug screening platform developed by the Broad Institute that barcodes cell lines and uses mixed-culture co-culture to simultaneously measure the response of multiple cell lines to the same drug.
The Project Quine team collaborates with institutions such as the Broad Institute, bringing together oncologists, biologists, and computational biologists.
GSEA由Broad研究所的Subramanian等人于2005年在PNAS上首次提出
All Facts (3)
PRISM is a high-throughput drug screening platform developed by the Broad Institute that barcodes cell lines and uses mixed-culture co-culture to simultaneously measure the response of multiple cell lines to the same drug.
50%UnverifiedThe Project Quine team collaborates with institutions such as the Broad Institute, bringing together oncologists, biologists, and computational biologists.
50%UnverifiedGSEA由Broad研究所的Subramanian等人于2005年在PNAS上首次提出
50%